7:34 am Palatin Technologies presents positive new data analyses demonstrating efficacy of bremelanotide in female hypoactive sexual desire disorder

more

View todays social media effects on PTN

View the latest stocks trending across Twitter. Click to view dashboard

See who Palatin is hiring next, click here to view